Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of an m6A-related lncRNA prognostic signature in colorectal cancer.

Journal of biochemical and molecular toxicology - 1 Jan 2023

Shi Zhi-Liang, Yang Xiaoling, Shen Cheng-Long, Zhou Guo-Qiang

Abstract excerpt

Data sets of colorectal cancer (CRC) were obtained from The Cancer Genome Atlas (TCGA), three N6-methyladenosine (m6A) subtypes were identified using 21 m6A-related long noncoding RNAs (lncRNAs) and differential m6A subtypes of different CRC tumors were determined in this study to evaluate the m6A expression and the prognosis of patients with CRC. Subsequently, eight key lncRNAs were identified based on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Immunotherapy
Share to Methyltransferases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to RNA, Long Noncoding

Source

Identifiers

PMID: 36205301
DOI: 10.1002/jbt.23239

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of an m6A-related lncRNA prognostic signature in colorectal cancer.PMID 36205301Read ↗

Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patientsSemantic proximity Read ↗

Evaluated the Role of N6-Methyladenosine-associated lncRNAs in Prognosis and Immune Microenvironment of Colorectal CancerSemantic proximity Read ↗

The Role of N6-Methyladenosine-associated lncRNAs in Immune Microenvironment and Prognosis of Colorectal CancerSemantic proximity Read ↗

Construction of a Prognostic m6A-related lncRNA Signature to Predict Immunotherapy and Chemotherapy Response in Hepatocellular CarcinomaSemantic proximity Read ↗

Bioinformatics Construction and Experimental Validation of a novel N6- Methylandenosine(m6A)-related lncRNA signature predicts prognosis and immune microenvironment in colon cancerSemantic proximity Read ↗

Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAsSemantic proximity Read ↗

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinomaSemantic proximity Read ↗

Identification and Validation of m6A-GPI Signatures as a Novel prognostic Model for Colorectal CancerSemantic proximity Read ↗

N6-methylandenosine-related lncRNAs play a key role in the prognosis and immune microenvironment of colon cancerSemantic proximity Read ↗

Gene signature and prognostic merit of M6a regulators in colorectal cancer.Semantic proximity Read ↗

Development and validation of a 13-m6a related lncRNA prognostic signature for lung adenocarcinomaSemantic proximity Read ↗

Identification and Validation of a Seven m6A-related lncRNAs Signature Predicting Prognosis of Ovarian CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.